Mangoceuticals (MGRX), Nuclea abandon $15M deal plan
Rhea-AI Filing Summary
MANGOCEUTICALS, INC. (MGRX) reported that it has mutually terminated its Business Combination Agreement with Nuclea Energy Inc. The agreement, signed July 29, 2026, had contemplated a strategic business combination between the two companies. Closing was conditioned on completing PIPE financing of at least $15,000,000 and depositing the full proceeds into escrow to be released to MGRX at or immediately after closing. Because the required PIPE Minimum Amount could not be raised on or before the Outside Date of August 21, 2026, the parties determined that the financing conditions to closing could not be satisfied on the contemplated terms and agreed on August 19, 2026 to terminate the agreement. The contract is now void except for specified confidentiality and general provisions that survive termination. Each party will bear its own transaction costs, and the parties have exchanged mutual releases of claims relating to the agreement and ancillary documents, subject to carve-outs for any willful breaches occurring on or before the termination date.
Positive
- None.
Negative
- Planned business combination with Nuclea Energy Inc. has been terminated, removing a contemplated strategic transaction.
- Required PIPE financing of at least $15,000,000 could not be raised by the August 21, 2026 Outside Date, indicating the contemplated funding conditions were not met.
8-K Event Classification
2 items: 1.02, 9.01
2 items
Item 1.02
Termination of a Material Definitive Agreement
Business
A significant contract was terminated, which may affect business operations or revenue.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
PIPE Minimum Amount: $15,000,000
Outside Date: August 21, 2026
Termination Date: August 19, 2026
3 metrics
PIPE Minimum Amount
$15,000,000
Minimum PIPE financing required to close the transaction under the Business Combination Agreement
Outside Date
August 21, 2026
Deadline by which the $15,000,000 PIPE Minimum Amount needed to be raised
Termination Date
August 19, 2026
Date Mangoceuticals, Inc. and Nuclea Energy Inc. mutually agreed to terminate the BCA
Key Terms
Business Combination Agreement, PIPE financing, PIPE Minimum Amount, Outside Date, +1 more
5 terms
Business Combination Agreement financial
"mutually agreed to terminate that certain Business Combination Agreement, dated as of July 29, 2026"
A business combination agreement is a detailed contract that lays out the terms for two companies to join together—covering price, how ownership will be split, the steps needed to close the deal, and what each side promises to do or avoid before closing. For investors it matters because the agreement determines potential changes in value, control, timing, and risk exposure—think of it like the playbook for a merger that shows who wins, who pays, and what could still derail the plan.
PIPE financing financial
"required to finalize and execute PIPE financing documentation, with the full proceeds"
Pipe financing is a way for companies to raise money quickly by selling new shares or bonds directly to investors, often before their stock is publicly traded or in the early stages of a project. It’s similar to a company securing a loan from investors, providing quick capital needed for growth or operations. For investors, it can offer opportunities for early involvement and potentially higher returns, but it may also carry increased risk due to the immediate nature of the deal.
PIPE Minimum Amount financial
"PIPE financing in an amount not less than fifteen million dollars (U.S. $15,000,000) (the “PIPE Minimum Amount”)"
Outside Date financial
"could not be raised on or prior to the Outside Date of August 21, 2026"
An outside date is the final contractual deadline by which a planned deal—such as a merger, acquisition, or financing—must be completed; if the transaction hasn’t closed by that date, parties typically gain the right to walk away or trigger agreed remedies. It matters to investors because it sets a clear timetable for when uncertainty should end, and approaching or missing the outside date can raise the chance of deal failure, renegotiation, or changes to valuation.
mutual releases financial
"the parties exchanged mutual releases of all claims relating to the BCA"
A mutual release is a legal agreement in which two parties agree to give up any present or future claims against each other arising from a specified matter, effectively ending disputes and preventing new lawsuits on those issues. For investors, mutual releases matter because they remove or limit potential liabilities and uncertainty—like both sides agreeing to drop their complaints and walk away—which can affect a company’s legal exposure, financial reserves, and perceived risk.
FAQ
What did MGRX disclose in this 8-K regarding the Nuclea Energy transaction?
MGRX disclosed that on August 19, 2026 it mutually agreed with Nuclea Energy Inc. to terminate their Business Combination Agreement, which had contemplated a strategic business combination between the companies.
Why was the MGRX business combination with Nuclea Energy terminated?
The business combination was terminated because the required PIPE financing of at least $15,000,000 could not be raised on or prior to the August 21, 2026 Outside Date, so the financing conditions to closing could not be satisfied.
What were the PIPE financing requirements described by MGRX (MGRX)?
The agreement required finalizing and executing PIPE financing documentation and depositing proceeds of at least $15,000,000 into escrow, with those proceeds to be released to Mangoceuticals, Inc. simultaneously with or immediately after closing.
How are costs and expenses handled after the termination for MGRX and Nuclea Energy?
Each party will bear its own costs and expenses incurred in connection with the Business Combination Agreement and the contemplated transaction, as stated in the mutual termination terms.
Do any provisions of the Business Combination Agreement between MGRX and Nuclea survive termination?
Yes. The company states that Section 9.5 (Access and Confidentiality), Section 12.2, and Article 13 (General) survive termination of the Business Combination Agreement.
Did MGRX and Nuclea provide any releases in connection with the termination?
Yes. The parties exchanged mutual releases of all claims relating to the Business Combination Agreement and ancillary documents, except with respect to any willful breach occurring on or before the termination date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
